Navigating First-Line Therapy Choices in Advanced Melanoma: Evidence, Patient Factors, and Shared Decision-Making
OR
Learning Objectives
- Review current evidence and clinical guidelines for first-line therapy options in advanced melanoma.
- Evaluate key patient-specific factors (e.g., tumor characteristics, comorbidities, genetic markers, and performance status) that influence treatment selection.
- Discuss the role of shared decision-making in aligning treatment plans with patient values, preferences, and quality-of-life considerations.
- Apply evidence-based strategies to optimize individualized care in the first-line treatment setting.
Explore more from your favourite experts – click their name to access their entire library of content.
Speakers
This program has been made possible through unrestricted support from BMS
